Table 2.
Demographic, Clinical, and Microbiological Data of the Studied Patients
| Gender (male) | 40 (58%) |
| Age (SD) | 52.7 ± 18.8 (range 17–85) |
| ICU length of stay (SD) | 14.7 ± 12.1 |
| APACHE II score (SD) | 23.1 ± 6.0 |
| Mortality | 23 (33.3%) |
| Diagnosis upon admission in the ICU (%) | |
| VAP and respiratory sepsis | 14 (20.3) |
| Severe trauma | 12 (17.4) |
| CNS infections and acute bacterial meningitis | 6 (8.7) |
| Peritoneal sepsis | 6 (8.7) |
| Stroke | 6 (8.7) |
| Soft tissue-related sepsis | 5 (7.2) |
| CNS trauma | 5 (7.2) |
| Other causes for sepsis | 6 (8.7) |
| Cardiac/pulmonary insufficiency | 2 (2.9) |
| Reanimation cardiorespiratory arrest | 2 (2.9) |
| Other | 5 (7.2) |
| ICU-acquired infections (%) | 65 |
| VAP | 23 (35.4) |
| Purulent tracheobronchitis | 11 (16.9) |
| Bacteremia | 14 (21.5) |
| Urinary tract infections | 3 (4.6) |
| Catheter-related infections | 3 (4.6) |
| Neurosurgical infections | 4 (6.2) |
| Tertiary peritonitis | 2 (3.1) |
| Skin and soft tissues infections | 2 (3.1) |
| Other foci | 3 (4.6) |
| Microorganisms detected (%) | 82 |
| Gram-negative rods | 61 (74.4) |
| Acinetobacter baumannii | 29 (35.4) |
| Pseudomonas aeruginosa | 10 (12.2) |
| Klebsiella pneumoniae | 9 (11.0) |
| Escherichia coli | 4 (4.9) |
| Other enterobacteria | 7 (8.5) |
| H. influenzae | 2 (2.4) |
| Gram-positive cocci | 21 (25.6) |
| Methicillin-susceptible Staphylococcus aureus | 9 (11.0) |
| Staphylococcus pneumoniae | 6 (7.3) |
| Methicillin-resistant S. aureus | 3 (3.7) |
| Enterococcus spp. | 1 (1.2) |
| Coagulase-negative Staphylococcus | 2 (2.4) |
APACHE II, Acute Physiology and Chronic Health Evaluation II; CNS, central nervous system; ICU, intensive care unit; SD, standard deviation; VAP, ventilator-associated pneumonia.